On Demand CE: Pharmacology and the CVD Patient

Pharmacology and the CVD Patient

Clinical management of chronic cardiovascular disease is a key component of the work of advanced practice nurses and RNs in the cardiology and primary care settings. PCNA has developed an annual pharmacology CE program to meet the clinical practice and re-certification needs of these clinicians.

This course curriculum is comprehensive approach to the pharmacologic issues related to the complex cardiovascular patient and covers the following topics:
  1. Complex Co-Morbidities
  2. Anti-thrombotic Therapies
  3. Over the Counter Medications and Supplements
Those who satisfactorily complete this course will earn 7.0 contact hours in the area of pharmacology. Independent self-paced pre- and post-course evaluation are included.

Credit: 7.00 Hour Pharmacology CE 
Cost: $35 for members, $85 for non-members

Take this Course

Faculty:

  • Joanna Sikkema DNP, ANP-BC
  • Kim Newlin RN, CNS, NP-C, FPCNA
  • Rhonda Cooper-DeHoff PharmD, MS, FAHA, FACC

Upon completion of this program, participants will be able to: 

  • Explore the consequences of polypharmacy for chronic disease management in the CVD patient
  • Identify the interactions between statin medications and antiretroviral therapies prescribed for patients with HIV infection
  • List the considerations for prescribing pharmacological agents in the “CVD secondary prevention cocktail” for patients with chronic inflammatory conditions and acute infection
  • Identify prescriptive variations for the patient with cardiovascular disease and chronic kidney disease
  • Summarize the indications for target-specific anticoagulants (TSOACS) for patients wiith non-valvular atrial fibrillation, venous Thromboembolic disease (VTE), and post-surgical VTE prophylaxis
  • Outline the safety considerations for patients on dual antiplatelet therapy who require concomitant anticoagulation therapy
  • Explore the mechanisms of reversal therapies for the patient undergoing anticoagulation
  • Identify the process of FDA regulation for over-the-counter medications (OTCs) versus dietary supplements
  • Describe the potential cardiac side effects associated with dietary supplements promoted as weight loss aids and energy supplements
  • Discuss the relationship of OTC medications and the risk of hypertension

This educational activity is provided by the Preventive Cardiovascular Nurses Association (PCNA). PCNA is approved as a provider of nurse practitioner continuing education (CE) programs by the American Association of Nurse Practitioners (AANP), provider number 030602.